When and where
Starts: Tuesday, 27 January 2026 - 11:00 (in 0 minutes)
Location:
Xtalks, Toronto, Canada
This event was automatically imported. Click the Source link below to double check the Start time and Location.
Event description
Alzheimer’s disease (AD) presents ongoing challenges for sponsors seeking earlier identification and more efficient therapeutic evaluation. Join experts from across IQVIA as they share the latest advances in AD clinical research. From early patient identification to leveraging breakthrough biomarkers and global site networks, the featured speakers will discuss actionable strategies for optimizing central nervous system (CNS) trials.
Discover how innovative approaches and operational expertise can help biotech and emerging biopharma sponsors lead therapeutic innovation, accelerate recruitment, overcome trial challenges and stay ahead in a rapidly evolving market.
Register for this webinar to learn how Alzheimer’s disease trial strategies can improve design, recruitment and decision-making.
Geolocation will be visible after you sign in.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 215
- Comments 0